Probiotics on display
More than 50 published clinical studies have been conducted on Chr. Hansen's BB-12 Bifidobacterium, LA-5 Lactobacillus acidophilus and L. casei 431.
More than 50 published clinical studies have been conducted on Chr. Hansen's BB-12 Bifidobacterium, LA-5 Lactobacillus acidophilus and L. casei 431. In studies evaluating these specific strains, researchers report enhanced intestinal well-being and positive effects on diarrhea, antibiotic-associated diarrhea, traveler's diarrhea and constipation, as well as enhanced immunity and positive effect on the skin disorder, atopic dermatitis. Proprietary encapsulation and tableting technology allows the probiotic bacteria to survive passage through the stomach and reach the small intestine. The company manufactures its probiotics using GMP and pharmaceutical standards.